BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178
December 28, 2016 at 06:43 AM EST
* Achillion announces clinical milestone for the advancement of JNJ-4178 in phase 2B development for chronic HCV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|